The qRT-PCR analysis revealed that PIAS3 was higher than in the human gastric cancer cells than in the BSA control group after treatment with 150 μM of PA for 12–24 h or treatment with 75–150 μM of PA for 24 h. The gene discussed is PIAS3; the disease is gastric cancer.